Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide vs Lamotrigine vs Valproic Acid in Childhood Absence Epilepsy
NCT00088452Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 2004
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in childhood absence epilepsy (CAE) comparing Ethosuximide, Lamotrigine and Valproic acid (3 arms). Primary endpoint: Number of Participants With Freedom From Treatment Failure at 16-20 Weeks of Double Blind Therapy. Started Jul 2004; status: completed.
02
Drugs
ethosuximidelamotriginevalproic acid
03
Conditions
childhood absence epilepsy (CAE)
Beyond the preview
Go deeper on NCT00088452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088452.